Quture International, Inc. Announces Shareholder Conference

Quture International, Inc. Announces Shareholder Conference Call
Hosted by Landon Feazell, Chairman and CEO 
DAYTONA BEACH, FL -- (Marketwire) -- 01/15/13 --   Quture
International, Inc. (OTCQB: QUTR) announced today that they will
conduct a shareholder conference call on Wednesday, January 23, 2013,
at 4:15 p.m. Eastern Standard Time to provide a management update and
strategic marketing and sales plan for 2013. Quture's Chairman and
CEO, Landon Feazell, will host the call. Shareholders, prospective
shareholders, analysts and other interested persons may access the
call by dial in fifteen minutes before using one of the following
1 (888) 895-5271 US Toll Free
 1 (847) 619-6547 US Toll
 Verbal Pass
Code: 34052754 
Quture will host quarterly shareholder calls in 2013 after more than
one year of being publicly traded. A bisseries of press releases have
chronicled the Company's progress and growth. As Quture continues its
growth and transition from development of its QualOptima product to
marketing and sales, the Company is strategically positioning for
success in the healthcare performance and outcomes analytics market.
Quture is actively engaged in potential agreements for national and
international sales contracts as a Breakthrough Application partner
with InterSystems Corporation. Quture is further committed to
changing the pedigree of the Company with announced and unannounced
additions to the Management Team and key independent contractors. As
these transitions mature, the Company has a commitment to our
shareholders as well as the investment community for maximum
disclosure and communication.  
An archived audio replay of the shareholder call will be made
available at www.quture.com shortly after the call and be posted for
one week. 
International, Inc. (QUTR) is the proven and experienced performance
and outcomes analytics company in the United States. The vision of
Quture is to connect all constituents in the global health and health
care community to clinically and financially focused and sound data
transformed through analytics to knowledge that empowers data-driven
decisions for results-driven success. As a "Breakthrough" Application
Partner of InterSystems Corporation, Quture's technology for
capturing, integrating and aggregating data on the InterSystems
Enterprise platform is unequalled. The Company's unique product
QualOptima develops a second generation CLINICAL database
implementing Quture's core competence of clinical content with
evidence-based metrics developed for more than 35 years. QualOptima
empowers clinical performance enhancement to achieve optimal patient
outcomes. Quture's brand is centered on the value proposition of
trust, transparency and independence. As the free enterprise solution
to improving health and healthcare while reducing costs, Quture is
positioned to become the leading clinical knowledge company in the
world. Quture International is a Nevada corporation trading under the
symbol QUTR. 
This release contains forward-looking statements, including, without
limitation, statements concerning our business and possible or
assumed future results of operations. Our actual results could differ
materially from those anticipated in the forward-looking statements
for many reasons including: our ability to continue as a going
concern, adverse economic changes affecting markets we serve;
competition in our markets and industry segments; our timing and the
profitability of entering new markets; greater than expected costs,
customer acceptance of our products or difficulties related to our
integration of the businesses we may acquire; and other risks and
uncertainties as may be detailed from time to time in our public
announcements and SEC filings. Although we believe the expectations
reflected in the forward-looking statements are reasonable, they
relate only to events as of the date on which the statements are
made, and our future results, levels of activity, performance or
achievements may not meet these expectations. We do not intend to
update any of the forward-looking statements after the date of this
document to conform these statements to actual results or to changes
in our expectations, except as required by law. There is no assurance
that a definitive agreement will be completed.  
For Further Information Contact:
Constellation Asset Advisors, Inc.
Jens Dalsgaard
+1 (415) 524-8500 
Mele Telitz
Director of Communications
Press spacebar to pause and continue. Press esc to stop.